Overview
Brand Institute has operated for over 30 years in the field of nomenclature and visual identity development. The agency has built a portfolio of more than 6000 brand names and works primarily in the pharmaceutical industry. Its expertise covers the creation of drug names, regulatory assistance and branding strategy. The company maintains partnerships with clients across the global pharmaceutical industry and offers services tailored to the specific requirements of international markets. More information at https://www.brandinstitute.com.
Services and expertise
Pharmaceutical nomenclature
Brand Institute develops brand and drug names whilst taking into account international regulatory requirements. The agency has approved 1700+ INN/USAN names and maintains high approval rates with major health authorities, including 88% with the FDA, 76% with the EMA and 97% with Health Canada.
Branding strategy
The agency supports the development of visual identities and brand strategies tailored to specific therapeutic sectors. Its areas of intervention include neurology, immunology, pain management and oncology, with clients including Eisai, Biogen, Vertex Pharmaceuticals and AstraZeneca/Daiichi Sankyo.
Regulatory compliance
Brand Institute has a team of regulatory compliance experts covering the major global pharmaceutical markets, including Japan, South Korea, Brazil, China and India. This expertise enables the optimisation of name approvals in varied regulatory environments.
